The inhibition of CSF1Rs with PLX3397 also rescues tau pathology and brain atrophy in a model with combined tau and amyloid pathologies, showing that DAMs in the proximity of amyloid plaques are resistant to CSF1R inhibition. This evidence concerns the gene MAPT and amyloidosis.